Christopher Nishan Garabedian 4
4 · AVI BIOPHARMA INC · Filed Apr 25, 2012
Insider Transaction Report
Form 4
Christopher Nishan Garabedian
Director
Transactions
- Award
Common Stock
2012-04-24+81,666→ 511,666 total - Award
Stock Option (right to buy)
2012-04-24+245,000→ 245,000 totalExercise: $0.90Exp: 2022-04-24→ Common Stock (245,000 underlying)
Footnotes (2)
- [F1]Of the 511,666 shares beneficially owned following the reported transaction, 81,666 relate to restricted stock units granted on the Transaction Date and 430,000 reflect shares of common stock directly beneficially owned by reporting person.
- [F2]This option is exercisable at the rate of 25% of the shares on April 24, 2013 and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on April 24, 2016.